Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Bronchiolitis Obliterans after SCT
NCT00656058Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2008
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in Bronchiolitis Obliterans (BO), sponsored by National Cancer Institute. Started Jun 2008; status: completed.
02
Drugs
montelukast
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on NCT00656058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656058.